Use of Rituximab and Risk of Re-hospitalization for Children with Neuromyelitis Optica Spectrum Disorder

被引：0
|
作者：
Gmuca, Sabrina [1 ]
Waldman, Amy T. [2 ]
Weiss, Pamela F. [3 ]
Gerber, Jeffrey S. [2 ]
机构：
[1] Childrens Hosp Philadelphia, Pediat Rheumatol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Rheumatol, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
112
引用
收藏
页码：164 / 165
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of rituximab in neuromyelitis optica spectrum disorder
    Radaelli, M.
    Moiola, L.
    Privitera, D.
    Rodegher, M.
    Colombo, B.
    Barcella, V.
    Sangalli, F.
    Esposito, F.
    Comi, G.
    Martinelli, V.
    JOURNAL OF NEUROLOGY, 2011, 258 : 261 - 262
  • [2] Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
    Ciron, J.
    Audoin, B.
    Bourre, B.
    Brassat, D.
    Durand-Dubief, F.
    Laplaud, D.
    Maillart, E.
    Papeix, C.
    Vukusic, S.
    Zephir, H.
    Marignier, R.
    Collongues, N.
    REVUE NEUROLOGIQUE, 2018, 174 (04) : 255 - 264
  • [3] Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
    Nosadini, Margherita
    Alper, Gulay
    Riney, Catherine J.
    Benson, Leslie A.
    Mohammad, Shekeeb S.
    Ramanathan, Sudarshini
    Nolan, Melinda
    Appleton, Richard
    Leventer, Richard J.
    Deiva, Kumaran
    Brilot, Fabienne
    Gorman, Mark P.
    Waldman, Amy T.
    Banwell, Brenda
    Dale, Russell C.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [4] Neuromyelitis optica spectrum disorder and rituximab: a multi-center analysis
    Novi, G.
    Capobianco, M.
    Gallo, F.
    Mataluni, G.
    Signori, A.
    Laroni, A.
    Annovazzi, P.
    Buttari, F.
    Rossi, S.
    Zuliani, L.
    Sica, F.
    Cocco, E.
    Benedetti, L.
    Malucchi, S.
    Frau, J.
    Sperli, F.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 436 - 436
  • [5] Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : NP3 - NP4
  • [6] Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
    Demuth, Stanislas
    Collongues, Nicolas
    Audoin, Bertrand
    Ayrignac, Xavier
    Bourre, Bertrand
    Ciron, Jonathan
    Cohen, Mikael
    Deschamps, Romain
    Durand-Dubief, Francoise
    Maillart, Elisabeth
    Papeix, Caroline
    Ruet, Aurelie
    Zephir, Helene
    Marignier, Romain
    De Seze, Jerome
    NEUROLOGY, 2023, 101 (04) : E438 - E450
  • [7] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Tatchaporn Ongphichetmetha
    Jiraporn Jitprapaikulsan
    Sasitorn Siritho
    Natthapon Rattanathamsakul
    Thammachet Detweeratham
    Naraporn Prayoonwiwat
    Scientific Reports, 14
  • [8] Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder
    Shi, Bingxin
    Zhao, Mangsuo
    Qiao, Liyan
    Huang, Fangjie
    Zhou, Shimei
    Wei, Yan
    Wang, Jing
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54
  • [9] Effectiveness of Rituximab and Oral Immunosuppressive Therapies in Neuromyelitis Optica Spectrum Disorder
    Abou, Widad
    Dresser, Laura
    Javed, Adil
    ANNALS OF NEUROLOGY, 2022, 92 : S138 - S138
  • [10] Neuromyelitis optica spectrum disorder and Rituximab: a multi-center analysis
    Novi, G.
    Capobianco, M.
    Gallo, F.
    Mataluni, G.
    Signori, A.
    Laroni, A.
    Annovazzi, P.
    Buttari, F.
    Rossi, S.
    Zuliani, L.
    Sica, F.
    Cocco, E.
    Benedetti, L.
    Frau, J.
    Malucchi, S.
    Sperli, F.
    Sormani, M. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 677 - 677
12345